Literature DB >> 28619805

Complete Genome Sequences of Two Human Oral Microbiome Commensals, Streptococcus salivarius ATCC 25975 and S. salivarius ATCC 27945.

Robert R Butler1, Jahna T A Soomer-James1, Michel Frenette2, Jean-François Pombert3.   

Abstract

Streptococcus salivarius strains are significant contributors to the human oral microbiome. Some possess unique fimbriae that give them the ability to coaggregate and colonize particular oral structures. We present here the complete genomes of Streptococcus salivarius Lancefield K-/K+ strains ATCC 25975 and ATCC 27945, which can and cannot, respectively, produce fimbriae.
Copyright © 2017 Butler et al.

Entities:  

Year:  2017        PMID: 28619805      PMCID: PMC5473274          DOI: 10.1128/genomeA.00536-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Streptococcus salivarius is a well-known commensal in the human oral microbiome. A variety of strains inhabit various subregions of the oral cavity (1) and presumably adapt to these niches. Certain S. salivarius strains are classified as Lancefield K− because they lack the K antigen (2). These strains have also been described as having fimbriae in a uniform distribution across their outer surface, differentiating them from K+ strains, which possess various fibrillar appendages (3). Fimbriae confer adherence properties, allowing for bacterial coaggregation with other members of the oral microbiota, such as other streptococci or periodontopathogens, and adherence to specific oral mucosa (4–6). Here, we present the complete circular genomes of two S. salivarius strains, ATCC 25975 (originally deposited as S. salivarius Andrewes and Horder) and ATCC 27945 (originally deposited as S. hominis), which are Lancefield K− and K+, respectively. Pure cultures of the two strains were provided by American Type Culture Collection (ATCC). Cultures of both strains were grown shaking at 37°C overnight in tryptone glucose yeast extract medium. Genomic DNA was extracted using the MasterPure Gram-positive (Epicentre, Madison, WI, USA) DNA purification kit with the addition of 2 units of mutanolysin per mL of culture. Sequencing was conducted on a PacBio RS II sequencer (Pacific Biosciences, Menlo Park, CA, USA) using two single-molecule real-time (SMRT) cells per strain and P5-C3 chemistry (one SMRT cell of ATCC 25975 was run using P6-C4 chemistry) at the University of Michigan DNA Sequencing Core (Ann Arbor, MI, USA). DNA was purified using AMPure XP beads (Beckman Coulter, Inc., Brea, CA, USA) and sheared to between 10 and 20 kb (N50: ATCC 25975, 13,296 bp; ATCC 27945, 11,893 bp) with g-TUBEs (Covaris, Woburn, MA, USA). Genomes were assembled using the HGAP2 protocol in SMRT-Analysis version 2.3.0 (7). The assembled contigs were trimmed to circularization and then corrected via sequential runs of the RS_Resequencing protocol (one run for the ATCC 25975 chromosome, three runs for the ATCC 25975 plasmid, and two runs for the ATCC 27945 chromosome). The ATCC 25975 assembly contained both a complete chromosome (2,199,793 bp, 39.9% G+C, 275.4× coverage) and a previously unidentified plasmid (126,555 bp, 35.9% G+C, 230.8× coverage). The ATCC 27945 assembly contained only the complete chromosome (2,108,274 bp, 40.2% G+C, 449.5× coverage). The genomes were annotated using the NCBI Prokaryotic Genome Annotation Pipeline version 3.1 (8). A total of 2,044/1,847 coding sequences, 68/68 tRNAs, 18/18 rRNAs, 4/4 ncRNAs, and 1/0 CRISPR array were annotated in the ATCC 25975/27945 genomes, respectively.

Accession number(s).

These complete genome projects were deposited in GenBank under the accession numbers CP015283.1 (ATCC 25975 chromosome), CP015284.1 (ATCC 25975 plasmid), and CP015282.1 (ATCC 27945 chromosome).
  7 in total

1.  Physiological classification of oral viridans streptococci.

Authors:  J M Hardie; G H Bowden
Journal:  J Dent Res       Date:  1976-01       Impact factor: 6.116

2.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

3.  Streptococcus salivarius fimbriae are composed of a glycoprotein containing a repeated motif assembled into a filamentous nondissociable structure.

Authors:  C Lévesque; C Vadeboncoeur; F Chandad; M Frenette
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

4.  Coaggregation of Streptococcus salivarius with periodontopathogens: evidence for involvement of fimbriae in the interaction with Prevotella intermedia.

Authors:  C Lévesque; J Lamothe; M Frenette
Journal:  Oral Microbiol Immunol       Date:  2003-10

5.  Streptococcus salivarius strains carry either fibrils or fimbriae on the cell surface.

Authors:  P S Handley; P L Carter; J Fielding
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

6.  The csp operon of Streptococcus salivarius encodes two predicted cell-surface proteins, one of which, CspB, is associated with the fimbriae.

Authors:  Céline Lévesque; Christian Vadeboncoeur; Michel Frenette
Journal:  Microbiology       Date:  2004-01       Impact factor: 2.777

7.  Immunochemical characterization of the carbohydrate antigens of serotype k and Lancefield group G "Streptococcus milleri".

Authors:  K Kitada; M Inoue
Journal:  Oral Microbiol Immunol       Date:  1996-02
  7 in total
  2 in total

Review 1.  Role of microbes in the pathogenesis of neuropsychiatric disorders.

Authors:  Aranyak Goswami; Frank R Wendt; Gita A Pathak; Daniel S Tylee; Flavio De Angelis; Antonella De Lillo; Renato Polimanti
Journal:  Front Neuroendocrinol       Date:  2021-05-04       Impact factor: 8.333

Review 2.  Oral microbiomes: more and more importance in oral cavity and whole body.

Authors:  Lu Gao; Tiansong Xu; Gang Huang; Song Jiang; Yan Gu; Feng Chen
Journal:  Protein Cell       Date:  2018-05-07       Impact factor: 14.870

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.